Monitoring Antimalarial Drug Efficacy

Ringwald, P.
April 2004
Clinical Infectious Diseases;4/15/2004, Vol. 38 Issue 8, p1192
Academic Journal
Presents letters to the editor on antimalarial drug efficacy, published in the April 15, 2004 issue of the journal "Clnical Infectious Diseases." Effects of the chemical compound sulfadoxine-pyrimethamine therapy; Results of clinical trials for drug resistance; Antimalarial drug efficacy in low transmission areas.


Related Articles

  • Screening of antimalarial drugs: An overview. Kalra, Bhupinder Singh; Chawla, S.; Gupta, P.; Valecha, N. // Indian Journal of Pharmacology;Feb2006, Vol. 38 Issue 1, p5 

    Efforts to discover and develop new antimalarial drugs have increased dramatically in recent years mainly because of resistance to existing antimalarial drugs. Selection of candidate drugs for clinical trials in man and the design of clinical protocols are based upon consideration of data from a...

  • Study confirms benefits of metronidazole gel tx. Guttman, Cheryl // Dermatology Times;Mar2005, Vol. 26 Issue 3, p58 

    The article cites a study which confirms benefits of metronidazole gel tx. Results of a large, nationwide, community-based phase 4 clinical trial reaffirm that metronidazole gel 0.75 percent (MetroGel, Galderma) safely and effectively treats rosacea while simultaneously improving quality of life...

  • The Role of Antimalarials in the Exacerbation of Psoriasis: A Systematic Review. Herman, Sari M.; Shin, Michael H.; Holbrook, Anne; Rosenthal, Donald // American Journal of Clinical Dermatology;2006, Vol. 7 Issue 4, p249 

    OBJECTIVE: To critically review the body of literature that refutes or supports the role of antimalarials in the exacerbation of psoriasis. METHODS: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were reviewed to identify English-language publications from...

  • Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study. Plowe, Christopher V.; Kublin, James G.; Dzinjalamala, Fraction K.; Kamwendo, Deborah S.; Mukadam, Rabia A. G.; Chimpeni, Phillips; Molyneux, Malcolm E.; Taylor, Terrie E. // BMJ: British Medical Journal (International Edition);3/6/2004, Vol. 328 Issue 7439, p545 

    Objective: To measure the efficacy of sulfadoxine-pyrimethamine treatment of falciparum malaria in Malawi from 1998 to 2002, after a change from chloroquine to sulfadoxine-pyrimethamine as first line treatment in that country in 1993. Design: Prospective open label drug efficacy study. Setting:...

  • Synthesis and Antimalarial Activity of 1,2,4,5-Tetraoxanes. Yuxiang Dong, J.D. // Mini Reviews in Medicinal Chemistry;Apr2002, Vol. 2 Issue 2, p113 

    Methods for formation of 1,2,4,5-tetraoxanes are summarized and antimalarial activities of 1,2,4,5-tetraoxanes are discussed.

  • NEUROCISTICERCOSIS EN PEDIATRIA. Valdez, Jorge Malagon // Medicina (Buenos Aires);2009, Vol. 69 Issue 1, p114 

    Cysticercosis: parasitic disease which affects 3% of the population in Mexico. It is considered that there are more than 50 million infected people in the world, endemic in Mexico, Central and South America, Africa, Asia and India. It is considered the most important neurological infectious...

  • Case report: Life-threatening hypoglycaemia associated with sulfadoxinepyrimethamine,a commonly used antimalarial drug Fairhurst, R.M.; Sadou, B.; Guindo, A.; Diallo, D.A.; Doumbo, O.K.; Wellems, T.E. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Sep2003, Vol. 97 Issue 5, p595 

    Abstract: Due to chloroquine resistance, several African countries have changed their first-line malaria treatmentto sulfadoxine-pyrimethamine (SP). In this report, we present a case of hypoglycaemic coma associated with SP, an adverse reaction that is likely to be underreported and expected to...

  • Academic medicine: time for reinvention. Caan, Woody // BMJ: British Medical Journal (International Edition);1/3/2004, Vol. 328 Issue 7430, p48 

    Presents a letter to the editor regarding the need for national strategies to improve clinical trials and medical research in Great Britain.

  • Scope of EPOC is clarified. McAuley, Laura M; Grimshaw, Jeremy; Zwarenstein, Merrick // BMJ: British Medical Journal (International Edition);7/12/2003, Vol. 327 Issue 7406, p106 

    Presents a letter to the editor of 'British Medical Journal' concerning the Cochrane Effective Practice and Organisation of Care Group (EPOC). Disagreement with Øvretveit and Gustafson that EPOC has developed methods to assess observational studies; Discussion of the EPOC purpose in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics